U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: September 30 - October 6, 2018
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: September 30 - October 6, 2018

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 10/02/2018
Location: Washington, DC
Subject: Health and Human Services Roundtable Meeting with Stakeholders: Direct-to-Consumer and Lower Drug Costs
FDA Participant/Group: LOWELL SCHILLER; LAUREN SILVIS; ANNA ABRAM;
Non FDA Participant/Group: Daniel Best, Eric Hargan, John M O'Brien, Stacy Amin, Thomas Keane, William Brady (Health and Human Services); Bob Bradway (Amgen Incorporated); Jim Stansel, Kelly Goldberg, Lori Reilly, Steve Ubl (Pharmaceutical Research and Manufacturers of America); Jeff Stewart (AbbVie Incorporated); Mark Alles (Celgene Corporation);

Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

Event Date: 10/03/2018
Location: Silver Spring, MD
Subject: Danone North America Public Benefit Corporation: Overview and Priorities Meeting
FDA Participant/Group: LAURA CARROLL; SUSAN MAYNE; PATRICIA HANSEN; ROBIN MCKINNON; CLAUDINE KAVANAUGH; STEPHEN OSTROFF; LARRY MORRIS;
Non FDA Participant/Group: Tara Smith (Michael Torrey Associates LLC); Chris Adamo, Philippe Caradec (Danone North America Public Benefit Corporation);

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/02/2018
Location: London, England
Subject: 3rd International Continuous Manufacturing Pharmaceuticals Symposium: Implementation, Integration and Regulatory Approaches: FDA's Stance on Advanced Manufacturing
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/04/2018
Location: La Jolla, CA
Subject: Cell & Gene Meeting on the Mesa: FDA's Efforts to Advance the Development and Approval of Cellular and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/02/2018
Location: Washington, DC
Subject: Alliance for Aging Research Annual Conference: 21st Century Cures Act Implementation Panel
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 10/04/2018
Location: Washington, DC
Subject: The National Evaluation System for Health Technology Coordinating Center Governing Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 10/01/2018
Location: College Park, MD
Subject: Meeting with McCormick Science Institute on Healthy Falvorful Eating
FDA Participant/Group: BLAKELEY FITZPATRICK; ROBIN MCKINNON; ANTONIA MATTIA; KARI BARRETT; LAUREN ZHOVMER; KASEY HEINTZ; LAURA CARROLL; JILLONNE KEVALA; MARY DITTO; CLAUDINE KAVANAUGH;
Non FDA Participant/Group: Kathleen Keller, Kristina Petersen, Penny Kris-Etherton (Pennsylvania State University); Christopher D'Adamo (University of Maryland School of Medicine); Lawrence Appel (Johns Hopkins University); Hamed Faridi (McCormick & Company Incorporated); Hang Xiao (University of Massachusetts Amherst); John Peters (University of Colorado); Guy Johnson (McCormick Science Institute);

Event Date: 10/02/2018
Location: Washington, DC
Subject: Private Label Manufacturers Association Washington Conference: FDA's Nutrition Innovation Strategy
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Private Label Manufacturers Association

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event